Lonza Group AG (OTCMKTS:LZAGY – Get Rating) shares crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $57.39 and traded as low as $56.18. Lonza Group shares last traded at $57.81, with a volume of 63,377 shares changing hands.
Wall Street Analyst Weigh In
A number of equities research analysts have issued reports on LZAGY shares. William Blair reaffirmed an “outperform” rating on shares of Lonza Group in a report on Friday, February 10th. Credit Suisse Group cut their price objective on shares of Lonza Group from CHF 700 to CHF 580 and set an “outperform” rating for the company in a report on Wednesday, December 7th. Seven equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $701.40.
Lonza Group Stock Up 2.7 %
The company has a current ratio of 1.86, a quick ratio of 1.27 and a debt-to-equity ratio of 0.15. The business has a 50-day moving average price of $57.39 and a 200 day moving average price of $52.84.
About Lonza Group
Lonza Group AG is engaged in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Biologics, Small Molecules, Cell and Gene, Capsule and Health Ingredients, and Corporate. The Biologics segment serves as contract development and manufacturing partner for biopharmaceuticals, catering customers for all clinical and commercial manufacturing needs throughout the product lifecycle.
- Get a free copy of the StockNews.com research report on Lonza Group (LZAGY)
- Don’t Miss Out: $2 Trillion Could be Headed to the Banking Sector
- A Weakening Economy Suggests Caution Before Buying Five Below
- Williams-Sonoma: Time To Buy At Rock-Bottom Prices
- Why DraftKings Could Keep Outperforming in 2023
- Charles Schwab And The Safest 30% You Can Make This Year
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.